Miyahara Yu, Funahashi Hideki, Haruta-Tsukamoto Ayaka, Hidaka Hiroto, Fujimoto Takako, Horinouchi Akira, Nishimori Toshikazu, Ishida Yasushi
Department of Psychiatry Faculty of Medicine University of Miyazaki Miyazaki city Japan.
Clin Case Rep. 2021 Nov 16;9(11):e05088. doi: 10.1002/ccr3.5088. eCollection 2021 Nov.
Venlafaxine has potential as a therapeutic option for patients with depressive disorder, migraine, and pruritus unresponsive to antihistamines.
文拉法辛对于患有抑郁症、偏头痛以及对抗组胺药无反应的瘙痒症患者而言,有作为一种治疗选择的潜力。